• In-depth discussion of Medical Marijuana Research and Practice
  • Featured speakers Dr. Jokūbas Žiburkus (Canntelligence), Dr. Dustin Sulak (Healer.com),
  • Panel hosted by CNBC’s Tim Seymour

Baltimore MD and Newton, MA, Nov. 05, 2018 (GLOBE NEWSWIRE) —  MariMed, Inc. (MRMD) proudly announces the Maryland Medical Cannabis Forum (MMCF) to offer Maryland medical professionals the opportunity to enhance their knowledge about medical cannabis treatment.  The Maryland Medical Cannabis Forum will take place on Thursday, November 8th, 5:00 pm at the Royal Sonesta Harbor Court Hotel, 550 Light St., Baltimore. The MMCF, a collaborative effort between MariMed, Tikun Olam, and MedChi of Maryland, was created to provide to the Maryland medical community current and credible information on the state of medical cannabis research and practices–and how it affects the 40,000-and-growing Maryland medical marijuana patients.

“Educating the medical community about cannabis’ clinical applications and supporting research is critical to increasing acceptance of cannabis as valid medical treatment and reducing the stigma associated with it,” stated Robert Fireman, CEO of MariMed.  “We are proud to sponsor this event with several of the industry’s top medical cannabis practitioners, researchers and experts.”

The MMCF panel will address critical topics for practitioners and their patients including clinical applications, current medical research, efficacy, observational vs clinical data, developing protocol and dosing for cannabinoid treatments with in-depth discussion on:

  • Cannabis and reduction in opioid dependency and other prescription medications
  • Cancer case studies utilizing cannabis for symptom relief and pain management
  • Cannabis treatment for neurological disorders such as Alzheimer’s, epilepsy and autism

Featured speakers include:

  • Dr. Jokūbas Žiburkus, Canntelligence CEO and Cofounder, neuroscientist and expert on the human endocannabinoid system and
  • Dr. Dustin Sulak, founder of Healer.com and specialist in cannabis & opioids research

CNBC’s Tim Seymour will host a discussion with the following panelists:

  • Joy Strand, Executive Director of the Maryland Medical Cannabis Commission
  • Sid Taubenfeld, CEO of Tikun Olam Pharma
  • Dr. Joel Meshulam, Internal Medicine, Privia Medical Group
  • Dr. Jokūbas Žiburkus, Canntelligence
  • Dr. Dustin Sulak, Founder of Healer.com

The MMCF is proud to have the support of MedChi (the Maryland State Medical Society), and sponsors including leading cannabis company and brand MariMed, Kind Therapeutics USA and Tikun Olam, and to establish the forum as a detailed resource for Maryland physicians to gather applicable information for their patients. For more information, visit www.medicalcannabisforum.org.

Additional MariMed upcoming events:

Search MariMed and post on social media with the hash tag #MedicatedByMarimed:
Twitter: @MariMedInc
Facebook: @MariMedInc
Instagram: MariMedInc
YouTube: MariMedInc